PLAU and breast carcinoma: Higher levels of uPA, uPAR and PAI-1 correspond to more aggressive disease for prostate-, cervical-, liver- and oral cancer [8], where uPA and PAI-1 have been validated as strong and independent prognostic factors for poor survival in primary breast cancer [10].